Financials
- Market Capitalization 106.58 M
- Employee 21
- Founded 2014
- CEO N/A
- Website www.blackdiamondtherapeutics.com
- Headquarter Massachusetts, United States
- FIGI BBG00MS4Y0W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.84
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3943 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.19 USD | +4.25% | +7.77% | +23.64% | -0.93% | 108.53 M USD | ||
| 3946 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.55 USD | +2.94% | -6.76% | +3.41% | -55.52% | 108.25 M USD | ||
| 3958 | ICCC ImmuCell Corporation - Common Stock | 11.72 USD | +5.78% | +11.73% | +23.11% | +84.86% | 106.03 M USD | ||
| 3976 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.93 USD | +0.17% | -1.33% | +1.72% | -1.50% | 101.87 M USD |